Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

2.

A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice.

Chow KP, Wu CC, Chang HY, Chang C, Chang YS.

Lab Anim. 2008 Apr;42(2):193-203. doi: 10.1258/la.2007.006037.

PMID:
18435877
3.

Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.

Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.

Haematologica. 2003 Dec;88(12):1324-35.

4.

Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.

Sheu LF, Chen A, Wei YH, Ho KC, Cheng JY, Meng CL, Lee WH.

Am J Pathol. 1998 Jan;152(1):63-74.

5.
6.

Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W.

Cancer Res. 2003 Jun 1;63(11):2982-9.

7.

Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo.

Cherney BW, Sgadari C, Kanegane C, Wang F, Tosato G.

Blood. 1998 Apr 1;91(7):2491-500.

8.

Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.

Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW.

Oncogene. 2004 May 27;23(25):4488-94.

PMID:
15064751
9.
10.

The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.

Miller WE, Cheshire JL, Baldwin AS Jr, Raab-Traub N.

Oncogene. 1998 Apr 9;16(14):1869-77.

11.

Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C.

J Virol. 2008 Jul;82(13):6721-33. doi: 10.1128/JVI.02250-07. Epub 2008 Apr 30.

12.

[Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].

Huang H, Huang PC.

Ai Zheng. 2003 Dec;22(12):1254-9. Chinese.

PMID:
14693046
13.
15.

[Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].

Smirnova KV, Diduk SV, Gurtsevich VÉ.

Biomed Khim. 2011 Jan-Feb;57(1):114-26. Russian.

PMID:
21516783
16.
17.

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

Zheng H, Li LL, Hu DS, Deng XY, Cao Y.

Cell Mol Immunol. 2007 Jun;4(3):185-96. Review.

18.

The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.

Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.

Virus Res. 2008 Feb;131(2):170-9. Epub 2007 Oct 25.

PMID:
17963943
19.

AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways.

Jang JH, Surh YJ.

Biochem Biophys Res Commun. 2005 Jun 17;331(4):1421-8.

PMID:
15883033

Supplemental Content

Support Center